Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04309812 · ClinicalTrials.gov registry record · NA
Transcranial Direct Current to Treat Epilepsy at Home
A NA study of Epilepsies, Partial, sponsored by Stanford University.
- Active
- Registry status
- NA
- Development phase
- 4
- Enrollment target
- 2
- Study locations
NCT04309812 is a NA study of Epilepsies, Partial that is active but no longer recruiting, run by Stanford University. The registered enrollment target is 4 participants, below the 71-participant average among 4 other Epilepsies, Partial trials with a reported enrollment target (94% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT04309812, a NA study of Epilepsies, Partial, is active but no longer recruiting, sponsored by Stanford University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
- 2
- Study locations
Study Summary
This is a placebo-controlled study of feasibility and potential effectiveness of transcranial direct current stimulation (tDCS) in the home environment to reduce seizures and EEG spikes.
Conditions Studied
Interventions
- DEVICE transcranial direct current stimulation (tDCS)
Study Locations (2)
California
- Stanford Hospital - Stanford
- Stanford University School of Medicine - Stanford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2021-05-26 |
| Est. Completion | 2027-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04309812
The ClinicalTrials.gov registry entry for NCT04309812 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 71-participant average among 4 other Epilepsies, Partial trials with a reported enrollment target (94% lower). The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Epilepsies, Partial appearing as the primary indexed condition, and to 1 intervention - of which transcranial direct current stimulation (tDCS) is the first listed.
NCT04309812 reports 2 study locations spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT04309812 about?
NCT04309812 is a clinical study titled "Transcranial Direct Current to Treat Epilepsy at Home". This is a placebo-controlled study of feasibility and potential effectiveness of transcranial direct current stimulation (tDCS) in the home environment to reduce seizures and EEG spikes.
What is the current status of trial NCT04309812?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 4 participants. The study started on 2021-05-26. Estimated completion is 2027-06-30.
What conditions does trial NCT04309812 study?
This clinical trial studies the following conditions: Epilepsies, Partial.
What interventions are being tested in trial NCT04309812?
The interventions under investigation include: transcranial direct current stimulation (tDCS) (DEVICE).
Who is sponsoring clinical trial NCT04309812?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04309812 being conducted?
This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Epilepsies, Partial
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Microburst Vagus Nerve Stimulator (VNS) Therapy Feasibility Study
COMPLETED · NA
-
Open-Label Extension Study Of Safety And Tolerability Of Pregabalin In Pediatric Patients With Partial-Onset Seizures
COMPLETED · Phase 3
-
Pediatric Epilepsy Study
COMPLETED · Phase 3
-
Safety, Tolerability, and Pharmacokinetic Study of Pregabalin in Pediatric Patients With Partial Onset Seizures
COMPLETED · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.